Zacks Investment Research on MSN1h
ISRG Stock Price Falls to 200-DMA: Should You Buy, Hold or Sell?
Shares of Intuitive Surgical ISRG have declined 16.5% in the past month, with the price currently trading around its 200-day ...
Zacks Investment Research on MSN1d
Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average
Adma Biologics (ADMA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ADMA broke through the 50-day moving average, which suggests a ...
Exclusive-Apple, Meta Likely to Face Modest Fines Over DMA Breaches, Sources Say
Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...
Salesforce Is Trading Below 200-DMA, But Goldman Sachs Sees Huge Stock Upside After Agentforce 2dx Unveil
Goldman Sachs analyst reiterates Buy on Salesforce with $400 PT. Positive on AI roadmap and growth potential, could yield early AI monetization.
EU Denies Picking on US Tech Giants, Says US Also Tackling Monopolisation
The comments by EU antitrust chief Teresa Ribera and EU tech chief Henna Virkkunnen came after U.S. House Judiciary Chair Jim ...